This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

William Fang
Vice President of Oligonucleotide and Peptide Development at WuXi TIDES


William Fang is the Vice President and Head of the Oligo/Peptide Development at WuXi TIDES, an integral part of WuXi AppTec. He has held various roles for over ten years with WuXi AppTec and has extensive experience in peptide R&D and manufacturing. Previously he worked at Zhejiang Runxin Pharmtech and Polypeptide labs. William received his bachelor’s degree from Beijing Medical University, his Master’s degree from Creighton University, and his MBA at UCLA.

Agenda Sessions

  • Amidite RSM Impurity Control and Impact on Oligonucleotide API Quality